{"id":203832,"date":"2025-11-27T23:25:19","date_gmt":"2025-11-27T23:25:19","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/203832\/"},"modified":"2025-11-27T23:25:19","modified_gmt":"2025-11-27T23:25:19","slug":"health-care-earnings-top-sp-500-on-strong-drug-hospital-demand","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/203832\/","title":{"rendered":"Health-Care Earnings Top S&#038;P 500 on Strong Drug, Hospital Demand"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody__3UcBa\" data-component=\"paragraph\">The largest American public health-care companies outperformed other industries in the third quarter, as higher new and specialty drug use, continued demand for weight-loss drugs and strong hospital visit trends boosted earnings. <\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody__3UcBa\" data-component=\"paragraph\">Among the 11 industry categories on the S&amp;P 500, health-care companies delivered the highest percentage of earnings beats in the period. It was also the best-performing quarter in more than four years for the industry. <\/p>\n","protected":false},"excerpt":{"rendered":"The largest American public health-care companies outperformed other industries in the third quarter, as higher new and specialty&hellip;\n","protected":false},"author":2,"featured_media":203833,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[110,112188,112189,718,6738,18,6915,135,475,474,19,17,188,17992,9222,190,112190],"class_list":{"0":"post-203832","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-cancer","9":"tag-cardinal-health-inc","10":"tag-cencora-inc","11":"tag-drugs","12":"tag-earnings","13":"tag-eire","14":"tag-food-and-drug-administration","15":"tag-health","16":"tag-health-care","17":"tag-healthcare","18":"tag-ie","19":"tag-ireland","20":"tag-markets","21":"tag-mckesson-corp","22":"tag-pharmaceutical","23":"tag-sp-500-index","24":"tag-ubs-group-ag-reg"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115624248831622099","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/203832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=203832"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/203832\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/203833"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=203832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=203832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=203832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}